Cabaletta Bio (CABA)
NASDAQ:CABA
US Market
Holding CABA?
Track your performance easily

Cabaletta Bio (CABA) Financial Statements

606 Followers

Cabaletta Bio Financial Overview

Cabaletta Bio's market cap is currently ―. The company's EPS TTM is $-1.91; its P/E ratio is -1.94; Cabaletta Bio is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.60. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -27.60M$ -28.03M$ -23.15M$ -16.45M$ -14.49M
EBITDA$ -26.56M$ -27.64M$ -22.81M$ -16.75M$ -14.29M
Net Income Common Stockholders$ -27.60M$ -25.05M$ -23.08M$ -16.45M$ -14.49M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 203.22M$ 223.84M$ 241.25M$ 164.39M$ 176.33M
Total Assets$ 217.42M$ 240.46M$ 253.65M$ 173.29M$ 184.64M
Total Debt$ 7.40M$ 8.17M$ 5.02M$ 4.27M$ 4.20M
Net Debt$ -195.82M$ -215.68M$ -236.23M$ -160.12M$ -172.13M
Total Liabilities$ 17.90M$ 18.74M$ 17.45M$ 12.36M$ 10.50M
Stockholders Equity$ 199.52M$ 221.72M$ 236.20M$ 160.92M$ 174.14M
Cash Flow-
Free Cash Flow$ -21.56M$ -24.80M$ -16.63M$ -12.67M$ -11.95M
Operating Cash Flow$ -20.79M$ -23.99M$ -16.45M$ -12.60M$ -11.89M
Investing Cash Flow$ 23.73M$ -812.00K$ 1.14M$ -65.00K$ -48.14M
Financing Cash Flow$ 379.00K$ 6.86M$ 93.05M$ 98.00K$ 94.26M
Currency in USD

Cabaletta Bio Earnings and Revenue History

Cabaletta Bio Debt to Assets

Cabaletta Bio Cash Flow

Cabaletta Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis